awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33436870-967EFD80-14AA-4436-9BF7-44075A657B67
Q33436870-967EFD80-14AA-4436-9BF7-44075A657B67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436870-967EFD80-14AA-4436-9BF7-44075A657B67
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population.
P2860
Q33436870-967EFD80-14AA-4436-9BF7-44075A657B67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436870-967EFD80-14AA-4436-9BF7-44075A657B67
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee2fdb785706a55214cf571846312b612af121ea
P2860
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.